Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years

New from #CR_UK https://t.co/HzCGpv0z4y Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years

New from #breastcancernow https://t.co/HzCGpv0z4y Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years

Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years https://t.co/eQ7jzhF5wD

RT @LguzzardiM: Frequency of pathogenic germline variants in #BRCA1, #BRCA2, #PALB2, #CHEK2 and #TP53 in #DCIS diagnosed in women under the…